These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 12652493)

  • 1. Impact of restenosis and disease progression on clinical outcome after multivessel stenting in diabetic patients.
    Loutfi M; Mulvihill NT; Boccalatte M; Farah B; Fajadet J; Marco J
    Catheter Cardiovasc Interv; 2003 Apr; 58(4):451-4. PubMed ID: 12652493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Provisional stenting for multivessel PCI.
    Han B; Liu L; Aboud M; Nahir M; Hasin Y
    Int J Cardiovasc Intervent; 2005; 7(1):46-51. PubMed ID: 16019615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
    Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of atherosclerotic disease progression on mid-term clinical outcome in diabetic patients in the drug-eluting stent era.
    Tousek P; Pavei A; Oreglia J; Martin G; Sharif F; Fajadet J; Farah B
    EuroIntervention; 2009 Mar; 4(5):588-92. PubMed ID: 19378678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of coronary revascularization (percutaneous or bypass) in patients with diabetes mellitus and multivessel coronary disease.
    Hee L; Mussap CJ; Yang L; Dignan R; Kadappu KK; Juergens CP; Thomas L; French JK
    Am J Cardiol; 2012 Sep; 110(5):643-8. PubMed ID: 22632829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome of patients undergoing low aggressive angioplasty combined with brachytherapy and short-term dual antiplatelet therapy for in-stent restenosis.
    Di Pede F; Buja P; Millosevich P; Grassi G; Celestre M; Zuin G; Marchetti C; Pizzi G; Antonello M; Bindoni L; Raviele A
    J Cardiovasc Med (Hagerstown); 2006 Oct; 7(10):731-6. PubMed ID: 17001233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Percutaneous therapy of bifurcation lesions with drug-eluting stent implantation: the Culotte technique revisited.
    Hoye A; van Mieghem CA; Ong AT; Aoki J; Rodriguez Granillo GA; Valgimigli M; Tsuchida K; Sianos G; McFadden EP; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
    Int J Cardiovasc Intervent; 2005; 7(1):36-40. PubMed ID: 16019613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the extent of coronary artery disease on outcomes after revascularization for unprotected left main coronary artery stenosis.
    Kim YH; Park DW; Kim WJ; Lee JY; Yun SC; Kang SJ; Lee SW; Lee CW; Hong MK; Park SW; Park SJ
    J Am Coll Cardiol; 2010 Jun; 55(23):2544-52. PubMed ID: 20513593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results.
    Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF;
    Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
    Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW;
    J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medium-term results from the clinical and angiographic follow-up of patients after angioplasty and implantation of sirolimus-eluting stents.
    Dardas PS; Tsikaderis DD; Mezilis NE; Hatzimiltiadis S
    Hellenic J Cardiol; 2005; 46(2):117-23. PubMed ID: 15847131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcomes after bare-metal stenting in diabetic patients with lesions carrying a low risk of restenosis.
    Woudstra P; Damman P; Beijk MA; Grundeken MJ; Harskamp RE; Koch KT; Henriques JP; Baan J; Vis MM; Piek JJ; Tijssen JG; de Winter RJ
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):26-33. PubMed ID: 22511590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone-eluting stents for the prevention of in-stent restenosis: evidence for a differential effect in insulin-dependent and non-insulin-dependent diabetic patients.
    van der Hoeven BL; Pires NM; Warda HM; Putter H; Quax PH; Schalij MJ; Jukema JW
    Int J Cardiol; 2008 Feb; 124(2):166-71. PubMed ID: 17408773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indications of coronary angioplasty and stenting in 2003: what is left to surgery?
    Poyen V; Silvestri M; Labrunie P; Valeix B
    J Cardiovasc Surg (Torino); 2003 Jun; 44(3):307-12. PubMed ID: 12832982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early and long-term results of unprotected left main coronary artery stenting: the LE MANS (Left Main Coronary Artery Stenting) registry.
    Buszman PE; Buszman PP; Kiesz RS; Bochenek A; Trela B; Konkolewska M; Wallace-Bradley D; Wilczyński M; Banasiewicz-Szkróbka I; Peszek-Przybyla E; Krol M; Kondys M; Milewski K; Wiernek S; Debiński M; Zurakowski A; Martin JL; Tendera M
    J Am Coll Cardiol; 2009 Oct; 54(16):1500-11. PubMed ID: 19699048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of coronary artery bypass grafting with drug-eluting stent implantation for the treatment of multivessel coronary artery disease.
    Yang JH; Gwon HC; Cho SJ; Hahn JY; Choi JH; Choi SH; Lee YT; Lee SH; Hong KP; Park JE
    Ann Thorac Surg; 2008 Jan; 85(1):65-70. PubMed ID: 18154782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes after management of restenosis or thrombosis of drug-eluting stents.
    Mishkel GJ; Moore AL; Markwell S; Shelton MC; Shelton ME
    J Am Coll Cardiol; 2007 Jan; 49(2):181-4. PubMed ID: 17222728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes and coronary revascularization.
    Flaherty JD; Davidson CJ
    JAMA; 2005 Mar; 293(12):1501-8. PubMed ID: 15784875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restenosis in the coronary stent is an argument for the surgical myocardial revascularization.
    Goleanu V; Tintoiu I; Iacob M; Pinte F; Gafencu M; Mocanu I; Mustaţă D; Droc I; Dumitraşcu G; Greere V; Neagoe G; Lazar O; Labont B; Teodorescu A; Ravescu M; Trandafir D
    Rom J Intern Med; 2003; 41(3):227-35. PubMed ID: 15526506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of vessel size on outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents: a subgroup analysis of the SIRTAX trial.
    Togni M; Eber S; Widmer J; Billinger M; Wenaweser P; Cook S; Vogel R; Seiler C; Eberli FR; Maier W; Corti R; Roffi M; Lüscher TF; Garachemani A; Hess OM; Wandel S; Meier B; Jüni P; Windecker S
    J Am Coll Cardiol; 2007 Sep; 50(12):1123-31. PubMed ID: 17868802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.